(Q47214377)

11 January 2018

title

Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer. (English)

1 reference

11 January 2018

1 reference

2

1 reference

11 January 2018

author name string

R Silvestrini

1

1 reference

11 January 2018

G Di Fronzo

3

1 reference

11 January 2018

A Morabito

4

1 reference

11 January 2018

P Valagussa

5

1 reference

11 January 2018

G Bonadonna

6

1 reference

11 January 2018

language of work or name

English

0 references

publication date

1 January 1986

1 reference

11 January 2018

Breast Cancer Research and Treatment

published in

1 reference

11 January 2018

volume

7

1 reference

11 January 2018

page(s)

161-169

1 reference

11 January 2018

issue

3

1 reference

11 January 2018

https://scigraph.springernature.com/pub.10.1007/bf01806246

exact match

0 references

cites work

Advanced breast cancer: Are the traditional stratification parameters still of value when patients are treated with combination chemotherapy?

1 reference

https://api.crossref.org/works/10.1007%2FBF01806246

Progesterone receptors as a prognostic factor in Stage II breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01806246

Oestrogen and progesterone receptors and disease-free interval in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01806246

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01806246

Oestrogen receptors in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01806246

Prognostic implication of estrogen receptor content in breast cancer.

21 January 2018

1 reference

12 December 2020

Standards for the assessment of estrogen receptors in human breast cancer. Report of a workshop on September 29, 1972, at the Antoni van Leeuwenhoek-Huis, Amsterdam

1 reference

12 December 2020

Cell proliferation and its relationship to clinical features and relapse in breast cancers

1 reference

12 December 2020

Estrogen receptors and long-term prognosis in breast cancer

1 reference

12 December 2020

Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy

1 reference

12 December 2020

Cell kinetics as a prognostic marker in node-negative breast cancer.

1 reference

12 December 2020

Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading

1 reference

12 December 2020

Prediction of early course of breast carcinoma by thymidine labeling

1 reference

12 December 2020

Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patients

1 reference

12 December 2020

Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

1 reference

12 December 2020

Estrogen receptor protein of breast cancer as a predictor of recurrence

1 reference

12 December 2020

Cancer of the breast: Size of neoplasm and prognosis

1 reference

12 December 2020

Intrastage prognostic heterogeneity: implications for adjuvant chemotherapy of breast cancer

1 reference

12 December 2020

Oestrogen receptors and survival in early breast cancer

1 reference

12 December 2020

The long-term prognostic significance of the thymidine labelling index in breast cancer

1 reference

12 December 2020

The value of estrogen and progesterone receptors in the treatment of breast cancer

1 reference

12 December 2020

Estrogen receptor assay in primary breast cancer and early recurrence of the disease

1 reference

12 December 2020

Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer

1 reference

12 December 2020

Contribution of prognostic factors to adjuvant chemotherapy in breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01806246

1 reference

11 January 2018

PubMed ID

3779114

1 reference

11 January 2018